✦ LIBER ✦

Effects of Nordic walking on cardiovascular risk factors in overweight individuals with type 2 diabetes, impaired or normal glucose tolerance

✍ Scribed by Fritz, T.; Caidahl, K.; Krook, A.; Lundström, P.; Mashili, F.; Osler, M.; Szekeres, F. L. M.; Östenson, C. G.; Wändell, P.; Zierath, J. R.

Book ID: 118757884
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 127 KB
Volume: 29
Category: Article
ISSN: 1520-7552
DOI: 10.1002/dmrr.2321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Nordic walking on health-rela

Effects of Nordic walking on health-related quality of life in overweight individuals with Type 2 diabetes mellitus, impaired or normal glucose tolerance

✍ T. Fritz; K. Caidahl; M. Osler; C. G. Östenson; J. R. Zierath; P. Wändell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Psychosocial factors are independent ris

Psychosocial factors are independent risk factors for the development of Type 2 diabetes in Japanese workers with impaired fasting glucose and/or impaired glucose tolerance

✍ M. Toshihiro; K. Saito; S. Takikawa; N. Takebe; T. Onoda; J. Satoh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Effects of low intensity exercise therap

Effects of low intensity exercise therapy on early phase insulin secretion in overweight subjects with impaired glucose tolerance and type 2 diabetes mellitus

✍ Ryoma Michishita; Naoko Shono; Takaki Kasahara; Toshiyuki Tsuruta 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 410 KB

Effects of rosglitazone on plasma adipon

Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes

✍ Kwame Osei; Trudy Gaillard; June Kaplow; Matthew Bullock; Dara Schuster 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Interim analysis of the effects of exena

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

✍ L. Blonde; E. J. Klein; J. Han; B. Zhang; S. M. Mac; T. H. Poon; K. L. Taylor; M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

In navigator, the angiotensin receptor b

In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance

✍ Michael J. Bloch; Jan N. Basile 📂 Article 📅 2010 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 246 KB